Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Am J Public Health ; 114(S1): S87-S91, 2024 Jan.
Article de Anglais | MEDLINE | ID: mdl-38207273

RÉSUMÉ

To increase community conversations about COVID-19 vaccine hesitancy, we distributed vaccine cardholders and conversation cards to 6000 newly vaccinated adults at vaccination sites and encouraged them to talk with unvaccinated friends and family members. In 257 onsite exit interviews, we found that cardholders and conversation cards were well liked, and most recipients expected to use them. Follow-up surveys two weeks later showed that 51% of respondents used a card to start a conversation and 41% gave a card to an unvaccinated friend or family member. (Am J Public Health. 2024;114(S1):S87-S91. https://doi.org/10.2105/AJPH.2023.307481).


Sujet(s)
COVID-19 , Adulte , Humains , COVID-19/prévention et contrôle , Vaccins contre la COVID-19 , Communication , Famille , Publications , Vaccination
2.
J Healthc Qual ; 44(3): 178-183, 2022.
Article de Anglais | MEDLINE | ID: mdl-35067537

RÉSUMÉ

ABSTRACT: A multidisciplinary team at a tertiary care Veterans Health Administration medical center created a standardized process to identify medically stable inpatients, to notify inpatient staff of available COVID-19 vaccine doses, and to coordinate inpatient vaccine administration. The team's goals were to mitigate vaccine waste while safely vaccinating as many patients as possible. Using a unique set of exclusion criteria and clinical judgment, a quality improvement team reviewed patients admitted to medicine teams to determine medical stability. Eligible, interested patients were listed in a secure shared file, and outpatient vaccine clinic staff communicated with inpatient nurse leaders regarding the availability of unadministered doses. Doses were transported to the hospital from the clinic and administered by inpatient nurses. Between January 8 and April 26, 2021, 105 patients were vaccinated with either the Moderna or the Pfizer-BioNTech COVID-19 vaccine during admission. Sixty-nine percent of the patients received a first dose, 27% received a second dose, and 4% received both doses. Forty-two percent of the patients vaccinated while inpatient identified as Black or African American compared with 28% of the vaccinated outpatients. No vaccine-related safety events were reported. This process demonstrates a viable approach to mitigating waste of COVID-19 vaccines and safely, efficiently, and equitably vaccinating an inpatient population.


Sujet(s)
Vaccins contre la COVID-19 , COVID-19 , Vaccin BNT162 , COVID-19/prévention et contrôle , Humains , Patients hospitalisés , Vaccination
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE